Name: UMIN ID:
Unique ID issued by UMIN | UMIN000037268 |
---|---|
Receipt number | R000042303 |
Scientific Title | Individualized dietary advice based on individual dietary assessment compared with conventional advice for Japanese adults with type 2 diabetes: a parallel-group randomized controlled clinical trial |
Date of disclosure of the study information | 2019/07/04 |
Last modified on | 2022/02/01 23:51:12 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/07/04 15:16:59 | ||
2 | Update | 2020/01/23 13:42:49 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
3 | Update | 2020/01/23 13:48:52 | Narrative objectives1 Narrative objectives1 Primary outcomes Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2020/01/23 14:17:44 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
5 | Update | 2020/01/23 14:27:58 | Organization Division name Division name Organization Division name Organization Division name Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Co-sponsor Co-sponsor Name of secondary funder(s) Name of secondary funder(s) Institutions |
|
6 | Update | 2020/01/23 14:28:56 | Number of participants that the trial has enrolled |
|
7 | Update | 2020/01/23 14:29:46 | Recruitment status |
|
8 | Update | 2020/08/03 14:06:13 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2020/08/03 14:12:00 | Interventions/Control_1 Interventions/Control_2 Key inclusion criteria |
|
10 | Update | 2020/08/03 14:12:46 | Number of participants that the trial has enrolled |
|
11 | Update | 2020/12/11 12:45:01 | Narrative objectives1 Primary outcomes Key secondary outcomes Key secondary outcomes |
|
12 | Update | 2020/12/11 12:59:27 | Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
13 | Update | 2020/12/11 13:02:12 | Organization Division name Organization Division name Organization Division name Institute Name of secondary funder(s) |
|
14 | Update | 2020/12/11 13:05:06 | Number of participants that the trial has enrolled |
|
15 | Update | 2020/12/11 13:07:34 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
16 | Update | 2021/02/25 11:23:54 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
17 | Update | 2021/02/25 11:25:56 | Narrative objectives1 |
|
18 | Update | 2021/02/25 11:26:17 | Primary outcomes |
|
19 | Update | 2021/02/25 11:47:55 | Blocking Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
20 | Update | 2021/02/25 11:52:57 | Address Address Address Address |
|
21 | Update | 2021/02/25 11:56:47 | Recruitment status Last follow-up date Date analysis concluded |
|
22 | Update | 2021/03/04 17:28:37 | Blocking |
|
23 | Update | 2021/04/13 22:08:34 | Primary outcomes Key secondary outcomes Key secondary outcomes |
|
24 | Update | 2021/05/09 12:13:09 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
25 | Update | 2021/05/11 20:52:05 | Key exclusion criteria Key exclusion criteria |
|
26 | Update | 2021/05/27 16:32:04 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
27 | Update | 2022/02/01 23:45:18 | URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
28 | Update | 2022/02/01 23:49:54 | Other related information Other related information |
|
29 | Update | 2022/02/01 23:51:12 | Publication of results |